The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 29, 2017

Filed:

Jul. 30, 2014
Applicant:

Smartcells, Inc., Whitehouse Station, NJ (US);

Inventors:

Todd C. Zion, Marblehead, MA (US);

Thomas M. Lancaster, Stoneham, MA (US);

Assignee:

SmartCells, Inc., Kenilworth, NJ (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 14/42 (2006.01); A61K 38/28 (2006.01); A61K 47/48 (2006.01); C07K 14/47 (2006.01); G01N 33/66 (2006.01);
U.S. Cl.
CPC ...
C07K 14/42 (2013.01); A61K 38/28 (2013.01); A61K 47/4823 (2013.01); A61K 47/48253 (2013.01); A61K 47/48261 (2013.01); C07K 14/4726 (2013.01); G01N 33/66 (2013.01); G01N 2333/4724 (2013.01);
Abstract

In one aspect, the disclosure provides cross-linked materials that include multivalent lectins with at least two binding sites for glucose, wherein the lectins include at least one covalently linked affinity ligand which is capable of competing with glucose for binding with at least one of said binding sites; and conjugates that include two or more separate affinity ligands bound to a conjugate framework, wherein the two or more affinity ligands compete with glucose for binding with the lectins at said binding sites and wherein conjugates are cross-linked within the material as a result of non-covalent interactions between lectins and affinity ligands on different conjugates. These materials are designed to release amounts of conjugate in response to desired concentrations of glucose. Depending on the end application, in various embodiments, the conjugates may also include a drug and/or a detectable label.


Find Patent Forward Citations

Loading…